Skin and Joints Podcast

๐ŸŽ™๏ธ Skin Joins Podcast Wrap-Up: Sunny Stories & Cool Poolsย ๐ŸŒž

We welcome back Dr. Michele Ramien, who graced our podcast last July from the sunny World Congress of Dermatology in Singapore.ย ๐ŸŒ Fast forward, she reflects on dermatology innovation from vibrant city of San Diego!ย ๐ŸŒด

Dr. Ramien shares a delightful (and chilly) San Diego story about renting a house wit, a freezing-cold pool, and a group of eager people determined to swim๐ŸŠโ€โ™‚๏ธโ„๏ธ

We deep dive into the exciting highlights from the American Academy of Dermatology conference. Dr. Ramien, attending AAD for the first time in a while, reveals fascinating pearls and๐Ÿฉบโœจ innovative treatments including the potential for disease remission in young patients, as well as fresh new insights on melasma and post-inflammatory hyperpigmentation in Asian skinย ๐ŸŒŸ

Dr. Ramien also touches on the importance of adapting treatments for different skin types and the promising future of pediatric dermatology.ย ๐Ÿ‘ถ๐Ÿ’ก

Learning Objectives:

1. ๐ŸŒ Understand the global advancements in dermatology from the AAD conference.
2. ๐Ÿงด Learn about innovative treatments for atopic dermatitis, including pediatric applications.
3. ๐ŸŽจ Explore the management of melasma and post-inflammatory hyperpigmentation in diverse skin types.
4. ๐Ÿง’ Discover the potential for disease remission in young patients with early and targeted treatments.

Tune in for a blend of personal stories, professional insights, and a sneak peek into the future of dermatological treatments.ย ๐Ÿ“š๐Ÿ”

Stay tuned, stay informed, and as always, keep your skin happyย ๐ŸŒŸ๐Ÿงด

Supported by an IME Grant from Pfizer
ย 

ย 

ABOUT Dr. Michele L. Ramien

Pediatric Dermatologist ย | ย Calgary

Dr. Michele Ramien is an academic dermatologist based at the Alberta Childrenโ€™s Hospital, in the foothills of the Rocky Mountains in Calgary, Canada. She has both pediatric and general medical dermatology practices, with a focus on teaching and mentoring the next generations and research interests in eczema management, patient education, and severe cutaneous reactions in children.

Dr. Ramien enjoys volunteer leadership positions as a way to meet colleagues across the country, like-minded and not, who believe that a small group of thoughtful, committed individuals can change and improve dermatology and delivery of care in Canada. ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

๐Ÿ“ปwww.skinandjoints.ca

โœ‰๏ธ[email protected]

๐ŸŽ™๏ธ More than Skin Deep Insights with Dr. Lauren Lam!๐ŸŽ™๏ธ

๐Ÿ‘ฉโ€โš•๏ธ๐Ÿ’ฌ As we get close to wrapping up our coverage of AAD 2024, get ready as we welcome back Dr. Lauren Lam. We dive deep into her recent experience at the AAD in sunny San Diego.ย ๐ŸŒž๐Ÿ–๏ธ

Learning Objectives:

1. ๐Ÿง  Understand the practical applications of translational medicine in dermatology, particularly in treating chronic skin conditions.
2. ๐Ÿ› ๏ธ Identify key clinical pearls and advancements in dermatology that can be immediately implemented in practice to improve patient care.

Whatโ€™s on the agenda for this mini-podcast drop?

1. ๐ŸŒŸ San Diego Stories: From bar hopping in a Japanese-themed spotย ๐ŸŒธ๐Ÿน to pelican watching at the pierย ๐Ÿฆฉ๐Ÿ“ธ, Lauren shares her unique experiences and the vibrant cultural mix that San Diego offers.
2. ๐Ÿ” Translational Medicine Takeaways: Discover how the latest advancements in bench-to-bedside research are transforming dermatological practices.ย ๐Ÿงฌ๐Ÿฉบ
3. ๐Ÿ’ก Clinical Pearls Galore:

• Hidradenitis Suppurativa Insights: Understand why de-roofing is essential even with biologics ๐Ÿฉน๐Ÿ”ฌ.
• Alopecia Areata Breakthroughs: Learn about the impact of JAK inhibitors ๐Ÿง‘โ€๐Ÿฆฒโžก๏ธ๐Ÿง‘โ€๐Ÿฆฐ.
• Pyoderma Gangrenosum Progress: Hear about the promising results of IL-36 inhibitors in treating this challenging condition ๐Ÿ’‰๐ŸŒŸ.

ย 

Join us for a lively episode that blends professional insights with personal anecdotes, and don't miss out on the laughter and wisdom Dr. Lam brings to the tableย ๐ŸŽงโœจ

ย 

ABOUT Dr. Lauren Lamย 

Dermatologistย  | ย Calgary

Dr. Lauren Lam is a Canadian & American board-certified dermatologist. She is a native Calgarian who completed her medical school training at the University of Calgary & her dermatology residency at the University of Alberta. Since graduating, Dr. Lam has become a Clinical Lecturer with the University of Alberta. Her particular passions in dermatology are acne & hidradenitis suppurativa deroofings. In addition to her regular practice, she volunteers on overseas medical trips. Her passion for providing care for under-served populations has taken her to Nunavut & rural Fiji. Outside of medicine, Dr. Lam is a proud aunt to 4 dogs, culinary enthusiast & international explorer.

ย 

ย 

ย 

ย 

๐Ÿ“ปwww.skinandjoints.ca

โœ‰๏ธ[email protected]

๐ŸŽ™๏ธ My CASMO (Canadian Skin Management in Oncology) Playbook: Part 2๐ŸŽ™๏ธ

Description:

In Part 2, dermooncologist Dr. Max Sauder returns to delve deeper into the CASMO algorithm. We navigate the complexities of managing severe cutaneous reactions in patients undergoing radiation. From identifying critical symptoms that necessitate urgent care to understanding the nuances of radiation dermatitis stages and risk factors, this episode is packed with expert insights and practical advice. ย We focus on 2 specific areas:

1. Assessment and Severity Evaluation: Guidance on evaluating the severity of skin toxicities, incorporating case studies to illustrate practical approaches.
2. Management Protocols: Exploration of practical management strategies and specific interventions for common skin toxicities, drawing on literature evidence and expert consensus.

Learning Objectives:

Identify Critical Symptoms:

• Recognize severe cutaneous adverse reactions and understand when urgent care is necessary based on symptoms like fever, skin pain, blisters, mucous membrane involvement, and abnormal labs.ย ๐Ÿšจ

Understand Radiation Dermatitis:

• Differentiate between acute and chronic radiation dermatitis.
• Learn the grading systems (CTCAE and RTOG) and their simplified applications in the CASMO algorithm.ย ๐Ÿ“Š

How to Manage Radiation Dermatitis:

• Implement effective treatment strategies for both dry and moist desquamation.
• Understand the role of topical steroids and topical over-the-counter dos and donโ€™ts๐Ÿ’Š

Recognize Risk Factors:

• Identify the factors that increase the risk of radiation dermatitis, considering the cancer type, radiation modality, and regimen.ย ๐Ÿงฌ
• Learn to manage photosensitivity reactions, particularly with targeted therapies.
• Explore strategies to ensure patient adherence to prescribed skincare and sun protection protocols, emphasizing the importance of these measures in minimizing treatment interruptions.ย ๐Ÿ›ก๏ธ

Photosensitivity Reactions:

• Understand the importance of proactive sun protection and the role of topical treatments.ย โ˜€๏ธ

Promote Adherence:

• Explore strategies to ensure patient adherence to prescribed skincare and sun protection protocols, emphasizing the importance of these measures in minimizing treatment interruptions.ย ๐Ÿ›ก๏ธ

Episode Highlights:

• Danger Zone: Learn to identify those serious skin reactions that need urgent care, stat!ย ๐ŸŒก๏ธ
• Radiation Dermatitis Deep Dive: Understand the stages and treatment of radiation dermatitis without getting lost in the weeds.ย ๐Ÿ“‹
• Risk Factors Unmasked: Get to know the usual suspects behind radiation dermatitis.ย ๐Ÿ”ฌ
• Photosensitivity Savvy: Protect patients from those sneaky photosensitivity reactions with top-notch tips. ย ๐ŸŒž
• Adherence Hacks: Keep patients sticking to their skincare and sun protection routines like glue. ย ๐Ÿ”„

Join us for a discussion perfect for a quick listen on your commute or work out๐ŸŽง

ย 

REFERENCES AND FURTHER RESOURCES:

1.ย ย ย ย ย ย  The role of skin care in oncology patients:ย STL-Supp-SkinCareOnc-v2-correction.pdf (skintherapyletter.com)

2.ย ย ย ย ย ย  Canadian general algorithm (cleanse, moisturize, protect):Canadian Skin Management in Oncology (CaSMO) Algorithm for Patients with Oncology Treatment-Related Skin Toxicities (skintherapyletter.com)

3.ย ย ย ย ย ย  Canadian radiotherapy algorithm:Canadian Skin Management in Oncology Group (Casmo) Algorithm for the Prevention and Management of Acute Radiation Dermatitis (skintherapyletter.com)

4.ย ย ย ย ย ย  Canadian immunotherapy algorithm:ย CaSMO Management of Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: A Practical Primer (skintherapyletter.com)

5.ย ย ย ย ย ย  Canadian hormonal therapy algorithm:ย Casmo Algorithm for Management of Hormonal Therapy-Related Cutaneous Adverse Effects in Oncology Patients (skintherapyletter.com)

6.ย ย ย ย ย ย  Canadian targeted therapy algorithm:Casmo Prevention and Management of Four Common Cutaneous Toxicities Associated with Targeted Cancer Therapies: Papulopustular Eruption, Xerosis, Paronychia, and Hand-Foot Skin Reaction (skintherapyletter.com)

ย 

ย 

ย 

ย 

Dr. Maxwell Sauder is a board-certified dermatologist with additional fellowship training. He earned his Doctor of Medicine at McMaster University and completed a residency in dermatology at The University of Ottawa. He completed fellowship training in Cutaneous Oncology at Harvard Medical School. He is a former instructor in dermatology at Harvard Medical School.

Dr. Sauder is currently an assistant professor at the University of Toronto.ย He is an onco-dermatologist at Princess Margaret Cancer Centre. He also practices at Toronto Dermatology Centre where he is the research director and the director of the Pigmented Lesion Clinic.

Well published in numerous peer-reviewed journals, Dr. Sauder has also authored several book chapters, been referenced on www.uptodate.com, and has won numerous awards including the Partnerโ€™s President Prize at Harvard and the Royal Collegeโ€™s Detweiler Fellowship Award. His publications have covered topics such as eczema, patient education, aesthetic dermatology, sun safety, psoriasis, biologics, adverse drug reactions, hemangiomas, contact dermatitis, cutaneous oncology, and a host of complex medical dermatology conditions.ย 

ย 

๐Ÿ“ปwww.skinandjoints.ca

โœ‰๏ธ[email protected]

ย 

ย 

๐Ÿ“ปwww.skinandjoints.ca

โœ‰๏ธ[email protected]

๐ŸŒž๐ŸŽงDermatologist Dr.Max Sauder joins us and navigates us through the complexities of modern dermatological care๐Ÿ’ก

๐ŸŽ™๏ธ My CASMO (Canadian Skin Management in Oncology) Playbook: Part 1๐ŸŽ™๏ธ

Get ready for a laugh and learn session as Dr. Jessica Asgarpour takes the co-hosting hot seat! This episode, weโ€™re diving headfirst into the CASMO project with dermo-oncologist Dr. Max Sauder. Weโ€™ll decode the CASMO algorithm, tackle the nitty-gritty of managing skin toxicities, and even uncover Dr. Sauder's secret summer plans. Buckle up!ย ๐ŸŽข

We're peeling back the layers of the CASMO project, an innovative approach to managing skin toxicities in cancer treatment. Can certain skin toxicities be prevented in patients? Is there a proactive skincare regimen that can be recommended?

1. Introduction to CaSMO and Skin Toxicities in Cancer Treatment:ย Overview of the significance of managing skin toxicities, introducing the CaSMO algorithm's development and objectives.
2. Prevention Strategies: Detailed discussion on general skincare measures recommended by CaSMO, including the rationale behind the use of cleansers and moisturizers to maintain skin hydration and integrity.

ย 

Episode Learning Objectives:

ย 

1. Understand the CASMO algorithm and its role in managing skin toxicities associated with cancer treatments.
2. Recognize the importance of a multidisciplinary approach in improving patient outcomes.
3. Identify practical proactive strategies for preventing and managing skin toxicities.
4. Learn about the impact of skin toxicities on patients' quality of life and how to address these issues.
5. Explore the role of various healthcare providers, including oncologists, nurses, and pharmacists, in supporting patients through their cancer journey.

ย 

Press play for a dose of dermatological delightย ๐ŸŽ™๏ธโœจ

Episode supported by an IME Grant from LA ROCHE POSAY

ย 

REFERENCES AND FURTHER RESOURCES:

1.ย ย ย ย ย ย  The role of skin care in oncology patients:ย STL-Supp-SkinCareOnc-v2-correction.pdf (skintherapyletter.com)

2.ย ย ย ย ย ย  Canadian general algorithm (cleanse, moisturize, protect):Canadian Skin Management in Oncology (CaSMO) Algorithm for Patients with Oncology Treatment-Related Skin Toxicities (skintherapyletter.com)

3.ย ย ย ย ย ย  Canadian radiotherapy algorithm:Canadian Skin Management in Oncology Group (Casmo) Algorithm for the Prevention and Management of Acute Radiation Dermatitis (skintherapyletter.com)

4.ย ย ย ย ย ย  Canadian immunotherapy algorithm:ย CaSMO Management of Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: A Practical Primer (skintherapyletter.com)

5.ย ย ย ย ย ย  Canadian hormonal therapy algorithm:ย Casmo Algorithm for Management of Hormonal Therapy-Related Cutaneous Adverse Effects in Oncology Patients (skintherapyletter.com)

6.ย ย ย ย ย ย  Canadian targeted therapy algorithm:Casmo Prevention and Management of Four Common Cutaneous Toxicities Associated with Targeted Cancer Therapies: Papulopustular Eruption, Xerosis, Paronychia, and Hand-Foot Skin Reaction (skintherapyletter.com)

ย 

ย 

ย 

Dr. Maxwell Sauder is a board-certified dermatologist with additional fellowship training. He earned his Doctor of Medicine at McMaster University and completed a residency in dermatology at The University of Ottawa. He completed fellowship training in Cutaneous Oncology at Harvard Medical School. He is a former instructor in dermatology at Harvard Medical School.

Dr. Sauder is currently an assistant professor at the University of Toronto.ย He is an onco-dermatologist at Princess Margaret Cancer Centre. He also practices at Toronto Dermatology Centre where he is the research director and the director of the Pigmented Lesion Clinic.

Well published in numerous peer-reviewed journals, Dr. Sauder has also authored several book chapters, been referenced on www.uptodate.com, and has won numerous awards including the Partnerโ€™s President Prize at Harvard and the Royal Collegeโ€™s Detweiler Fellowship Award. His publications have covered topics such as eczema, patient education, aesthetic dermatology, sun safety, psoriasis, biologics, adverse drug reactions, hemangiomas, contact dermatitis, cutaneous oncology, and a host of complex medical dermatology conditions.ย 

ย 

๐Ÿ“ปwww.skinandjoints.ca

โœ‰๏ธ[email protected]

ย 

ย 

๐Ÿ“ปwww.skinandjoints.ca

โœ‰๏ธ[email protected]

๐ŸŽ™๏ธ Melinda Knows Best at the AAD! ๐ŸŒŸ

Weโ€™ve got a special LATEBREAKER episode for you, continuing our coverage from the American Academy of Dermatology in San Diego!ย 

๐Ÿ‘Ÿ๐Ÿ’ก Pro Tip: Don't miss Dr. Gooderhamโ€™s advice on navigating massive convention centers in style and comfort!

We dive into the highly anticipated Delta 3 study, shedding light on long-term safety and efficacy of Delgocitinib cream for Chronic Hand Eczema.ย 

• Subjects who completed the 16-week treatment period in one of the parent trials DELTA 1 and DELTA 2 were treated with twice daily delgocitinib cream as needed to control their chronic hand eczema for 36 weeks.

Practical Tips for Dermatology Practices ๐Ÿฅ๐Ÿ’ผ

• Adapting treatment plans for chronic hand eczema.
• Benefits of as-needed treatment approaches for better patient outcomes.

Dr. Gooderhamโ€™s Conference Adventures ๐Ÿ›ซ๐Ÿ‘ฉโ€โš•๏ธ๐Ÿ‘จโ€โš•๏ธ

• Dr. Gooderham also shares her intriguing encounters from Toronto to San Diego, including a surprise meeting with April Armstrong and an old friend from med school. ๐Ÿ›ซ

Episode Learning Objectives:

1. Understand the primary and secondary endpoints of the Delta 3 study and its implications for treating chronic hand eczema.
2. Learn about the safety profile of Delgocitinib cream and its significance in long-term treatment plans.
3. Gain insights into real-world application of delgocitinib and patient adherence strategies for topical treatments

Lace up those sneakers, grab a protein bar, and join us for a walk through the latest dermatological advancements! ๐Ÿฅพ๐Ÿซ

๐ŸŽ™๏ธ Melinda Knows Best at the AAD โ€“ where expert insights meet real-world application (pun intended)๐Ÿ“๐Ÿ“

Episode supported by an IME Grant from LEO Pharma

ย 

ย 

ABOUT Dr.Melinda Gooderham, MD, FRCPC ( Dermatology)

Dermatologistย  | ย Torontoย 

ย 

Toronto, ON

Melinda Gooderham MD MSc FRCPC Dr. Gooderham is a Dermatologist and Medical Director at the SKiN Centre for Dermatology and an Investigator with Probity Medical Research. She is an Assistant Professor at Queens University and a Consultant Physician at the Peterborough Regional Health Centre. She is a fellow of the Royal College of Physicians and Surgeons of Canada.

Dr. Gooderham has been the principal investigator for over 200 clinical trials and she practices with a focus on inflammatory diseases of the skin. She also contributes to several peer-reviewed dermatology publications as an associate editor, reviewer, and has been an author of 205 articles. She enjoys lecturing to global audiences on new therapies for skin diseases.

ย 

References

1. Gooderham M. Long-term safety and efficacy of delgocitinib cream for up to 36 weeks in adults with chronic hand eczema: results of the phase 3 open-label extension DELTA 3 trial. Presented at: 2024 American Academy of Dermatology Annual Meeting; March 8-12, 2024; San Diego, CA.

ย 

ย 

ย 

๐Ÿ“ปwww.skinandjoints.ca

โœ‰๏ธ[email protected]

๐ŸŽ™๏ธ๐ŸŒž Tight Spaces & Hair-Raising Breakthroughs โ€“ Live from AAD San Diego! ๐ŸŽ™๏ธ๐ŸŒด

Join Skin and Joints Podcast AAD Guest Faculty and Vancouver based dermatologist, Dr,Diana Diao, as she navigates the cramped quarters of a historic boutique hotel in the Gaslamp Quarterโ€”tiny rooms, weird noises, and all!ย ๐Ÿจ๐Ÿ˜…

Dr. Diao explore groundbreaking sessions on alopecia areata, revealing innovative treatments and valuable clinical insightsย that are shaping the future of dermatology.ย 

ย ๐ŸŒŸ๐Ÿ’ŠDon't miss out on Dr. Diao's top clinical takeaways that could revolutionize treatment approaches for dermatologists everywhere. Whether it's systemic therapies for extensive scalp involvement or tailored treatments for unique patient profiles, this episode is packed with insights that promise to enhance patient care.ย 

๐Ÿ’ฌ Tune in, transform your approach with pearls that could change your practice overnight!ย 

๐ŸŽงโœจ #SkinJointsPodcast #DermatologyInDepth

ย 

Learning Objectives:

1. Gain Insight into New Treatments for Alopecia Areata: Learn about the latest advancements and clinical trials discussed at AAD, including newly approved treatments and their application in real world practice.
2. Appreciate the Psychosocial Aspects of Dermatological Conditions: Recognize the significant emotional and social challenges faced by patients with alopecia areata and the importance of addressing these in real world practice.
3. Implement Clinical Pearls in Practice: Discover actionable tips and strategies that can be immediately applied to improve patient outcomes.

ย #SkinAndJointsPodcast #DermatologyDeepDive #SanDiegoSunย 
Episode supported by an IME Grant from Pfizer and Bausch Health.

ย 

ABOUT DR. ย DIANA DIAO FRCPC, FAAD

Dr. Diana Diao is a Dermatologist and a Clinical Instructor in the Department of Dermatology and Skin Science at the University of British Columbia. She is a consultant dermatologist at both Vancouver General Hospital and St. Paulโ€™s Hospital. Dr. Diao practices medical and procedural dermatology, with a special interest in using energy-based modalities such as lasers to treat a variety of skin conditions.

Dr. Diao completed both her Medical Doctorate degree and dermatology residency training at the University of British Columbia, and is a Fellow of the Royal College of Physicians and Surgeons of Canada. Dr. Diao is a mother, a published author, and has presented her work at conferences such as the World Congress of Dermatology and the American Academy of Dermatology meetings. Dr. Diao is also fluent in Mandarin.

ย 

๐Ÿ“ปwww.skinandjoints.ca

โœ‰๏ธ[email protected]

๐ŸŽ™๏ธ๐ŸŒž An AAD 2024 Coles Notes Deep Dive โ€“ Welcome to a potpourri episode of the Skin and Joints Podcast, streaming from the vibrant city of San Diego.ย 

Join us as we sit down with Guest Faculty dermatologist expert the much-anticipated Dr. Mark Kirchhoff, whose voice is as deep and profound as his insights into dermatology.ย ๐ŸŽค๐Ÿ’ฌ

Medical Innovations Uncovered:

โ€ข Key Sessions from AAD: We traverse the entire meeting with key insights into s๐ŸŽ™๏ธ๐ŸŒž An AAD 2024 Coles Notes Deep Dive โ€“ Welcome to a potpourri episode of the Skin and Joints Podcast, streaming from the vibrant city of San Diego.ย 

Join us as we sit down with Guest Faculty dermatologist expert the much-anticipated Dr. Mark Kirchhoff, whose voice is as deep and profound as his insights into dermatology.ย ๐ŸŽค๐Ÿ’ฌ

Medical Innovations Uncovered:

โ€ข Key Sessions from AAD: We traverse the entire meeting with key insights into significant advancements, focusing on HS, AD, PsO and AA.

โ€ข Late Breaker Highlights: An overview of the most cutting-edge studies presented, including potential new therapies and their implications for future treatment protocols including rethinking long term disease remission to the exploration of new and novel therapeutic targets.

ย 

Learning Objectives:

• Delve into Dermatological Innovations: Get the latest updates on groundbreaking treatments for HS, AA, AD and PsO as well as other skin conditions from the AAD meeting.ย ๐Ÿ”ฌ๐Ÿ’ก
• Discuss Future Directions in Dermatology: Examine the potential shifts in treatment approaches and how they align with current patient needs and future therapeutic strategies.ย ๐ŸŒŸ

ย 

Dr. Kirchhoff also reflects on the changing landscape of medical conferences influenced by social media and digital dissemination of knowledge

Join us for a blend of professional insights and personal anecdotes that promise to educate and entertain. Tune in to catch Dr. Kirchhoffโ€™s voice and vision for the future of dermatology!ย ๐Ÿ“š๐ŸŽง

ย #SkinAndJointsPodcast #DermatologyDeepDive #SanDiegoSunย 

Episode supported by an IME Grant from Pfizer and Bausch Health.

ย 

ย 

ABOUT DR. MARK KIRCHHOF,MD, PHD, FRCPC, FAAD

Dr. Mark Kirchhof is the Division Head of Dermatology in the Faculty of Medicine at the University of Ottawa and The Ottawa Hospital. After receiving his Bachelor of Science in molecular biology from McMaster University, Dr. Kirchhof completed his medical degree and PhD at Western University in London, Ontario. His PhD research involved studies of the signalling pathways important to immune system regulation. He then went on to complete his dermatology residency at the University of British Columbia in Vancouver, British Columbia.

Until August 2017, Dr. Kirchhof was the Education Director at Queenโ€™s University in Kingston, Ontario, where he coordinated and led undergraduate, post-graduate and continuing medical education activities. He has published over 40 peer-reviewed papers and maintains a keen interest in clinical and bench-to-bedside research. He has been invited to speak at local, national and international meetings. His clinical interests are varied and he sees both pediatric and adult patients.ignificant advancements, focusing on HS, AD, PsO and AA.

โ€ข Late Breaker Highlights: An overview of the most cutting-edge studies presented, including potential new therapies and their implications for future treatment protocols including rethinking long term disease remission to the exploration of new and novel therapeutic targets.

ย 

Learning Objectives:

• Delve into Dermatological Innovations: Get the latest updates on groundbreaking treatments for HS, AA, AD and PsO as well as other skin conditions from the AAD meeting.ย ๐Ÿ”ฌ๐Ÿ’ก
• Discuss Future Directions in Dermatology: Examine the potential shifts in treatment approaches and how they align with current patient needs and future therapeutic strategies.ย ๐ŸŒŸ

ย 

Dr. Kirchhoff also reflects on the changing landscape of medical conferences influenced by social media and digital dissemination of knowledge

Join us for a blend of professional insights and personal anecdotes that promise to educate and entertain. Tune in to catch Dr. Kirchhoffโ€™s voice and vision for the future of dermatology!ย ๐Ÿ“š๐ŸŽง

ย #SkinAndJointsPodcast #DermatologyDeepDive #SanDiegoSunย 

Episode supported by an IME Grant from Pfizer and Bausch Health.

ย 

ย 

ABOUT DR. MARK KIRCHHOF,MD, PHD, FRCPC, FAAD

Dr. Mark Kirchhof is the Division Head of Dermatology in the Faculty of Medicine at the University of Ottawa and The Ottawa Hospital. After receiving his Bachelor of Science in molecular biology from McMaster University, Dr. Kirchhof completed his medical degree and PhD at Western University in London, Ontario. His PhD research involved studies of the signalling pathways important to immune system regulation. He then went on to complete his dermatology residency at the University of British Columbia in Vancouver, British Columbia.

Until August 2017, Dr. Kirchhof was the Education Director at Queenโ€™s University in Kingston, Ontario, where he coordinated and led undergraduate, post-graduate and continuing medical education activities. He has published over 40 peer-reviewed papers and maintains a keen interest in clinical and bench-to-bedside research. He has been invited to speak at local, national and international meetings. His clinical interests are varied and he sees both pediatric and adult patients.

ย 

๐Ÿ“ปwww.skinandjoints.ca

โœ‰๏ธ[email protected]

๐ŸŒโœจ Welcome to a US-Canada Acne Dialogueย Where we Unpack the Art of Acne Treatment Customization and Master Practical Clinical Pearls.๐ŸŽ™๏ธ๐Ÿ๐Ÿ‡บ๐Ÿ‡ธ

๐ŸŒ‰๐Ÿ”ฌSkin and Joints Podcast Faculty Dermatologist duo, Dr.Linda Stein Gold and Dr. Mimi Tran, converge to unravel a MasterClass on the latest in acne management, distilled straight from the AAD with a focus on defining the role and place of a new topical hormonal anti-androgen agent and why all isotretinoin options are not the sameย ๐ŸŒž

๐ŸŽฏLearning Objectives:

1. Advances in Acne Care Innovation:ย Gain practical insights into the newly released AAD acne guidelines, how they should be used for the patient in front of you, straight from one of the Faculty members that helped create it! Dr.Stein Gold deep dives into the critical balance between guideline recommendations and the nuanced needs of individual patients, highlighting the importance of cost considerations, treatment efficacy, and the patient-practitioner partnership in dermatology.
2. Dive into the world of new acne therapies, including the groundbreaking topical androgen receptor blocker and its role in reducing sebum production. A leap forward in topical acne treatment!ย ๐Ÿ†•๐Ÿ’ก
3. Beyond the Surface:ย Learn about the significance of vehicle design in topical medications โ€” a crucial factor for efficacy, tolerability, and patient satisfaction. It's not just what's inside that counts, but how it's delivered.ย ๐Ÿšš๐Ÿ’Š
4. The Isotretinoin Evolution:ย Explore the latest advancements in isotretinoin formulations that promise enhanced absorption without the need for fatty meals, paving the way for more effective and flexible treatment options.ย ๐Ÿฝ๏ธโžก๏ธ๐Ÿ’ง
5. Empowering Patients:ย Embrace the power of visual progress tracking with baseline and follow-up photographs, fostering patient engagement and adherence. A picture is worth a thousand words, especially in acne treatment!ย ๐Ÿ“ธ๐Ÿ“ˆ

๐ŸŒŸ Stay tuned

ย 

#HealthcareCrossroads #AcneInnovation #USCanadaConnectionย ๐ŸŽง๐Ÿ’ฌ

EPISODE Supported by ย SUN Pharma

ย 

Dermatologist, Detroit, MI

Linda Stein Gold, MD, is Director of Dermatology Clinical Research at Henry Ford Health System in Detroit, Michigan, as well as Division Head of Dermatology at Henry Ford Health System in West Bloomfield, Michigan.

Dr. Stein Gold earned her undergraduate degree at the Wharton School of the University of Pennsylvania and her medical degree from the University Of Pennsylvania School Of Medicine in Philadelphia and completed her residency in dermatology at Henry Ford Hospital in Detroit.

Dr. Stein Gold is very active in clinical research on a variety of dermatologic conditions, including the treatment of chronic plaque-type psoriasis, actinic keratosis, atopic dermatitis, acne vulgaris, seborrheic dermatitis, and rosacea. She has published articles in journals such as the Journal of the American Academy of Dermatology, Cutis, the Journal of Drugs in Dermatology among others. She is a frequent national and international lecturer on acne, rosacea, psoriasis, actinic keratosis, alopecia, viral infections, atopic dermatitis, and fungal infections, at grand rounds and medical society meetings. She is also the treasurer of the National Acne and Rosacea Society and a member of the National Psoriasis Foundation Medical Board.

Dermatologist, Winnipeg, MB

Dr Mimi Tran is a dual board-certified Dermatologist in Canada and the USA. After graduating from medical school at the University of Calgary, she pursued a rigorous Dermatology residency at the University of British Columbia. She has trained in centres across Canada. With her extensive experience from practicing in Vancouver, Dr Tran decided to bring her exceptional skills and expertise back to her hometown of Winnipeg. Dr. Tran practices in both Medical and Cosmetic Dermatology. ย She has a particular interest in Skin Cancer, Acne, Eczema, Psoriasis, as well as Cosmetic Dermatology.

๐Ÿ“ปwww.skinandjoints.ca

โœ‰๏ธ[email protected]

๐ŸŒž๐ŸŽ™๏ธ Live from AAD 2024 in San Diego!๐ŸŽ™๏ธ๐ŸŒž

We're bringing you the freshest insights straight from the sun-kissed halls of the AAD 2024 conference in San Diego.ย ๐ŸŒดโœจ With the iconic Hard Rock Hotel glittering in the back, we dive deep into the world of acne - and oh boy, do we have some groundbreaking news for you!ย ๐Ÿงด๐Ÿ’ฅ

๐Ÿคฉ Joining us are our guest Faculty tag team from Toronto who share their pearls of wisdom under the California sun. We're buzzing about the latest in acne attack plans, especially the shiny new AAD guidelines dropped like a hot potato at the end of January.ย ๐Ÿ“œ๐Ÿ”

๐Ÿงช From the comforting confirmation of our daily dermatological dos to the intriguing nods towards affordability and access - this episode is packed!ย ๐ŸŽ‰ We navigate through the sea of sessions to spotlight the crรจme de la crรจme on acne management.ย ๐Ÿš€

ย 

1. Understand the 2024 Acne Guidelines: Gain a comprehensive understanding of the new AD acne guidelines released in January 2024, including their recommendations for the management of acne with topical antibiotics, retinoids, benzoyl peroxides, and the strategic use of oral therapies .
2. Discuss the Impact of Drug Pricing: Delve into the discussion around how drug pricing influences the listing of therapies as first, second, or third line in the guidelines, and consider the implications of this from both U.S. and Canadian perspectives.
3. Consider New and Emerging Therapies: Identify and evaluate new and emerging therapies in acne treatment, including the anticipation of new triple combination therapies and the introduction of clascotarone, highlighting their alignment with guideline recommendations for combination therapies
4. Address the BPO Controversy:And just when you thought it couldn't get more exciting, we unboxed the potential of emerging therapies and dived into the benzene buzz surrounding benzoyl peroxide and how to counsel patients on these issues.

Here's to clearer skies and even clearer skin ahead!ย ๐ŸŒˆ๐Ÿ‘ฉโ€โš•๏ธ๐Ÿ‘จโ€โš•๏ธ #AAD2024 #AcneAwareness #DermatologyDeepDive

ย 

EPISODE Supported by BAUSCH Health.ย 

ย 

Dermatologist, Toronto, ONย 

Dr. Sam Hanna is at the forefront of innovation in cosmetic dermatology and is passionate about improving patient skin health with laser treatments, light treatments, and injectable solutions. Dr. Hanna specializes in achieving natural-looking outcomes by way of a holistic approach to cosmetic medicine. A board certified dermatologist and recognized expert in the use of cosmetic injectables including fillers, neuromodulators and sodium deoxycholate, Dr. Hanna is regularly called upon to share his expertise with physician colleagues in lectures and hands-on-training courses. He also lectures on a variety of issues such as dermatology workforce and skin disease treatments.

Dr. Hanna is the Medical Director at Dermatology On Bloor as well as a Diplomate of the American Board of Dermatology. He travels the world sharing his expertise and insights with the global medical and dermatology community.

Dr. Hanna was one of the first Dermatologists in Canada who was trained and certified to offer the Vacuum-Assisted Cellulite Band Release procedure for treatment of cellulite on the thighs and buttocks.

An active clinical trialist, Dr. Hanna has served as a principal investigator for numerous cosmetic & medical clinical trials with Probity Medical Research.

ย 

About Dr.Jessica Asgarpour, MD, FRCPC Dermatologistย | Toronto, ONย 

Dr. Jessica Asgarpour is a Canadian and American board-certified dermatologist.She practices medical, surgical and cosmetic dermatology with a special interest in hidradenitis suppurativa, eczema, acne, psoriasis, and womenโ€™s health. She is currently working at Canadian Dermatology Centre and is also a clinical associate at Womenโ€™s College Hospital. She is a lecturer at University of Toronto and an active sub-investigator for ongoing clinical trials.

ย 

ย 

๐Ÿ“ปwww.skinandjoints.ca

โœ‰๏ธ[email protected]

ย 

ย 

๐Ÿ“ปwww.skinandjoints.ca

โœ‰๏ธ[email protected]

๐ŸŒž๐Ÿ” Photoprotection in Skin of Colour: The Role of Visible Light and New Perspectives on Sun Protectionย 

Episode Sneak Peek:

• ๐Ÿค” Debunking Myths: Think all skin reacts the same under the sun? Think again! Weโ€™re tackling 3 big misconceptions about photodamage across the Fitzpatrick Skin Types.

Hot Seat Confessions: Our panel of dermatologist experts faces the heat ๐Ÿ”ฅ, answering ย burning questions:

• Is photodamage consistent across all skin colors?
• Can melanin alone ward off the sunโ€™s advances?
• Do broad-spectrum sunscreens offer the ultimate armor against all sunlight villains?

๐ŸŒฟ๐Ÿ’กAntioxidants: The Hype or Hero? We dissect the buzz around antioxidants in sunscreens โ€“ are they just a marketing myth or a must-have in your skincare arsenal?

๐ŸŒž๐Ÿงด ย And yes, donโ€™t forget your sunscreen, no matter your shade!

Episode Learning Objectives

• Identify and correct misconceptions regarding the significance of photoprotection across different populations with a focus on darker skin phenotypes.
• Understand the detrimental effects of visible light on skin health.
• Explore the function of Reactive Oxygen Species (ROS) and antioxidants in sunscreen formulations.
• Apply tailored photoprotection regimens for individuals of all Fitzpatrick Skin Types (FSTs)

#SkinAndJointsPodcast #ShadesOfBrown #BeyondLabels #SunProtectionForAll

EPISODE Supported by EUCERIN.ย 

ย 

About Dr.Tasneem F. Mohammad, MD FAAD ย 

Dermatologist, Detroit, MI

Tasneem F. Mohammad, MD FAAD is a Staff Physician in the Henry Ford Health System Department of Dermatology in Detroit, MI where she also completed her residency training and ย a photomedicine and pigmentation research fellowship. Her clinical and research interests include photomedicine, vitiligo, and pigmentary disorders. She has served on various committees for the Global Vitiligo Foundation, Skin of Color Society, and American Academy of Dermatology. ย 

ย 

About Dr. Jennifer Beecker MD, FRCPC, CCFP(EM), DABD

Dermatologist, Ottawa, ON

Dr. Jennifer Beecker is a Royal College-certified dermatologist who is fully trained and certified in three separate medical specialties: Dermatology, Emergency Medicine and Family Medicine. In addition, she has earned American board-certification as a dermatologist by the American Board of Dermatology. Dr. Beecker is an active Staff Dermatologist at The Ottawa Hospital and Assistant Professor at the University of Ottawa. The range of conditions in which Dr. Beecker holds expertise includes medical dermatology, skin cancer, as well as cosmetic dermatology.

ย 

Dr. Beecker is a national expert in skin cancer detection and prevention. Dr. Beecker founded the Melanoma and Pigmented Lesion Clinic at The Ottawa Hospital academic teaching centre. She is the only dermatologist in Canada using this specialized equipment at a teaching hospital. Dr. Beecker trains medical residents and medical students in this clinic, as well as in general dermatology clinics. She is also Vice-Chair of the Dermatology Examination Committee at the Royal College of Physicians and Surgeons of Canada, which sets and conducts the exam for dermatology residents graduating and attempting to obtain Canadian certification as a dermatologist.

ย 

As Research Director for the Division of Dermatology at The Ottawa Hospital and a Clinical Investigator in the Clinical Epidemiology Program at the Ottawa Hospital Research Institute (OHRI), Dr. Beecker conducts and supervises many research studies, and has multiple publications in the medical literature. She is invited to lecture about dermatology locally, nationally, and internationally, and is frequently interviewed by the media, especially on topics such as sun protection and skin cancer. In 2020, Dr. Beecker was awarded the prestigious โ€œPresidentโ€™s Cup Awardโ€ by the Canadian Dermatology Association for the second time having also received this award in 2016. She is now President Elect of the Canadian Dermatology Association.

ย 

๐Ÿ“ปwww.skinandjoints.ca

โœ‰๏ธ[email protected]

ย 

ย 

๐Ÿ“ปwww.skinandjoints.ca

โœ‰๏ธ[email protected]